BlackRock Health Sciences Trust
BME
Get informed when a big investor buys or sells
+ FollowMarket Cap$571.5M
Close$
$1.23
97.2% downside
Current Fair Value
97.2% downsideOvervalued by 97.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $571.50 Million |
|---|---|
| Enterprise Value | $572.19 Million |
| Dividend Yield | $3.15 (7.11%) |
| Earnings per Share | $5.92 |
| Beta | 0.59 |
| Outstanding Shares | 12,924,103 |
Return
| Return on Equity | 13.64% |
|---|---|
| Return on Assets | 13.57% |
| Return on Invested Capital | 14.37% |
Valuation & Multiples
| P/E Ratio | 5.49 |
|---|---|
| PEG | -0.72 |
| Price to Sales | 6.28 |
| Price to Book Ratio | 1.0 |
| Enterprise Value to Revenue | 6.08 |
| Enterprise Value to EBIT | 6.93 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 19.88%▼ 0.56% |
|---|---|
| Total Invested | $111.05M▲ 9.13% |
| Investors Holding | 81▲ 3.00% |
ESG Score
No data
About BlackRock Health Sciences Trust
CEO: John Perlowski BlackRock Health Sciences Trust’s (BME) (the 'Trust') investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment ob...